Sign in
4

Changes in Ownership

Edesa Biotech, Inc. Filed Acc 0001171843-26-003802

Chief Financial Officer acquired 64,609 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Weiler Peter J. Chief Financial Officer 2026-05-27 Grant or award +64,609 129,609 D
Loading xslF345X06/ownership.xml…